237 related articles for article (PubMed ID: 2966154)
1. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a).
Ye SQ; Trieu VN; Stiers DL; McConathy WJ
J Biol Chem; 1988 May; 263(13):6337-43. PubMed ID: 2966154
[TBL] [Abstract][Full Text] [Related]
2. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins.
Trieu VN; McConathy WJ
Biochemistry; 1990 Jun; 29(25):5919-24. PubMed ID: 2143418
[TBL] [Abstract][Full Text] [Related]
4. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
[TBL] [Abstract][Full Text] [Related]
5. Lp(a) interactions.
McConathy WJ; Trieu VN
Prog Lipid Res; 1991; 30(2-3):195-203. PubMed ID: 1840454
[TBL] [Abstract][Full Text] [Related]
6. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
[TBL] [Abstract][Full Text] [Related]
7. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
8. Binding of thyroxine to human plasma low density lipoprotein through specific interaction with apolipoprotein B (apoB-100).
Benvenga S; Cahnmann H; Gregg R; Robbins J
Biochimie; 1989 Feb; 71(2):263-8. PubMed ID: 2495826
[TBL] [Abstract][Full Text] [Related]
9. Quantification of apo[a] and apoB in human atherosclerotic lesions.
Pepin JM; O'Neil JA; Hoff HF
J Lipid Res; 1991 Feb; 32(2):317-27. PubMed ID: 1829751
[TBL] [Abstract][Full Text] [Related]
10. ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B).
Yang CY; Xie YH; Yang M; Quion JA; Gotto AM
J Protein Chem; 1995 Oct; 14(7):503-9. PubMed ID: 8561846
[TBL] [Abstract][Full Text] [Related]
11. The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction.
Trieu VN; Olsson U; McConathy WJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):17-22. PubMed ID: 7717972
[TBL] [Abstract][Full Text] [Related]
12. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.
Ikewaki K; Cain W; Thomas F; Shamburek R; Zech LA; Usher D; Brewer HB; Rader DJ
J Lipid Res; 2004 Jul; 45(7):1302-11. PubMed ID: 15102883
[TBL] [Abstract][Full Text] [Related]
13. Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB.
Gries A; Fievet C; Marcovina S; Nimpf J; Wurm H; Mezdour H; Fruchart JC; Kostner GM
J Lipid Res; 1988 Jan; 29(1):1-8. PubMed ID: 2451704
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B-38.9 does not associate with apo[a] and forms two distinct HDL density particle populations that are larger than HDL.
Groenewegen WA; Averna MR; Pulai J; Krul ES; Schonfeld G
J Lipid Res; 1994 Jun; 35(6):1012-25. PubMed ID: 8077841
[TBL] [Abstract][Full Text] [Related]
15. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B.
Choi SY; Sivaram P; Walker DE; Curtiss LK; Gretch DG; Sturley SL; Attie AD; Deckelbaum RJ; Goldberg IJ
J Biol Chem; 1995 Apr; 270(14):8081-6. PubMed ID: 7713910
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus).
Laplaud PM; Beaubatie L; Rall SC; Luc G; Saboureau M
J Lipid Res; 1988 Sep; 29(9):1157-70. PubMed ID: 2972788
[TBL] [Abstract][Full Text] [Related]
18. Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a].
Fless GM; Pfaffinger DJ; Eisenbart JD; Scanu AM
J Lipid Res; 1990 May; 31(5):909-18. PubMed ID: 2143212
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG
Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor.
Young SG; Peralta FP; Dubois BW; Curtiss LK; Boyles JK; Witztum JL
J Biol Chem; 1987 Dec; 262(34):16604-11. PubMed ID: 3680266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
